95 related articles for article (PubMed ID: 31384398)
1. Correction: Regulation of E-cadherin localization by microtubule targeting agents: rapid promotion of cortical E-cadherin through p130CAS/Src inhibition by eribulin.
Dybdal-Hargreaves NF; Risinger AL; Mooberry SL
Oncotarget; 2019 Jul; 10(45):4719-4720. PubMed ID: 31384398
[TBL] [Abstract][Full Text] [Related]
2. Regulation of E-cadherin localization by microtubule targeting agents: rapid promotion of cortical E-cadherin through p130Cas/Src inhibition by eribulin.
Dybdal-Hargreaves NF; Risinger AL; Mooberry SL
Oncotarget; 2018 Jan; 9(5):5545-5561. PubMed ID: 29464017
[TBL] [Abstract][Full Text] [Related]
3. Relation among p130Cas, E-cadherin and beta-catenin expression, clinicopathologic significance and prognosis in human hepatocellular carcinoma.
Guo C; Liu QG; Yang W; Zhang ZL; Yao YM
Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):490-6. PubMed ID: 18842495
[TBL] [Abstract][Full Text] [Related]
4. Correction: An updated meta-analysis of the prognostic value of decreased E-cadherin expression in ovarian cancer.
Yu L; Hua X; Yang Y; Li K; Zhang Q; Yu L
Oncotarget; 2018 Apr; 9(28):20220. PubMed ID: 29733082
[TBL] [Abstract][Full Text] [Related]
5. Eribulin targets a ch-TOG-dependent directed migration of cancer cells.
Chanez B; Gonçalves A; Badache A; Verdier-Pinard P
Oncotarget; 2015 Dec; 6(39):41667-78. PubMed ID: 26497677
[TBL] [Abstract][Full Text] [Related]
6. Correction: Reduced E-cadherin expression is correlated with poor prognosis in patients with bladder cancer: a systematic review and meta-analysis.
Xie Y; Li P; Gao Y; Gu L; Chen L; Fan Y; Zhang F; Zhang X
Oncotarget; 2019 Apr; 10(27):2657. PubMed ID: 31080556
[TBL] [Abstract][Full Text] [Related]
7. Correction: The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer.
Adamo B; Ricciardi GRR; Ieni A; Franchina T; Fazzari C; Sanò MV; Angelico G; Caruso M; Tuccari G; Adamo V
Oncotarget; 2019 Jan; 10(8):917. PubMed ID: 30783520
[TBL] [Abstract][Full Text] [Related]
8. Protein tyrosine phosphatase activity is necessary for E-cadherin-activated Src signaling.
McLachlan RW; Yap AS
Cytoskeleton (Hoboken); 2011 Jan; 68(1):32-43. PubMed ID: 20925106
[TBL] [Abstract][Full Text] [Related]
9. Correction: Combined inhibition of PI3K and Src kinases demonstrates synergistic therapeutic efficacy in clear-cell renal carcinoma.
Caroline R; Sofia G; Catherine P; Remi B; Pierre C; Olivier B; Laurent G; Valentin A; Claude C; Odile F
Oncotarget; 2019 Mar; 10(22):2236. PubMed ID: 31040915
[TBL] [Abstract][Full Text] [Related]
10. Src kinase inhibition restores E-cadherin expression in dasatinib-sensitive pancreatic cancer cells.
Dosch AR; Dai X; Gaidarski Iii AA; Shi C; Castellanos JA; VanSaun MN; Merchant NB; Nagathihalli NS
Oncotarget; 2019 Feb; 10(10):1056-1069. PubMed ID: 30800218
[TBL] [Abstract][Full Text] [Related]
11. Posttranslational modification of E-cadherin by core fucosylation regulates Src activation and induces epithelial-mesenchymal transition-like process in lung cancer cells.
Shao K; Chen ZY; Gautam S; Deng NH; Zhou Y; Wu XZ
Glycobiology; 2016 Feb; 26(2):142-54. PubMed ID: 26443198
[TBL] [Abstract][Full Text] [Related]
12. Tamoxifen treatment promotes phosphorylation of the adhesion molecules, p130Cas/BCAR1, FAK and Src, via an adhesion-dependent pathway.
Cowell LN; Graham JD; Bouton AH; Clarke CL; O'Neill GM
Oncogene; 2006 Dec; 25(58):7597-607. PubMed ID: 16799644
[TBL] [Abstract][Full Text] [Related]
13. Expression of p130cas, E-cadherin and β-catenin and their correlation with clinicopathological parameters in non-small cell lung cancer: p130cas over-expression predicts poor prognosis.
Miao Y; Li AL; Wang L; Fan CF; Zhang XP; Xu HT; Han Y; Liu Y; Wang E
Folia Histochem Cytobiol; 2012 Oct; 50(3):392-7. PubMed ID: 23042269
[TBL] [Abstract][Full Text] [Related]
14. Correction: P-cadherin mutations are associated with high basal Wnt activity and stemness in canine mammary tumor cell lines.
Timmermans-Sprang E; Collin RWJ; Henkes A; Philipsen M; Mol JA
Oncotarget; 2020 Feb; 11(5):573. PubMed ID: 32082491
[TBL] [Abstract][Full Text] [Related]
15. p130Cas, E-cadherin and β-catenin in human transitional cell carcinoma of the bladder: expression and clinicopathological significance.
Hu X; Ruan Y; Cheng F; Yu W; Zhang X; Larré S
Int J Urol; 2011 Sep; 18(9):630-7. PubMed ID: 21672035
[TBL] [Abstract][Full Text] [Related]
16. Focal adhesion targeting of v-Crk is essential for FAK phosphorylation and cell migration in mouse embryo fibroblasts deficient src family kinases or p130CAS.
Yeo MG; Sung BH; Oh HJ; Park ZY; Marcantonio EE; Song WK
J Cell Physiol; 2008 Mar; 214(3):604-13. PubMed ID: 17786957
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal-epithelial Transition and Tumor Vascular Remodeling in Eribulin Chemotherapy for Breast Cancer.
Kashiwagi S; Asano Y; Goto W; Takada K; Takahashi K; Hatano T; Tanaka S; Takashima T; Tomita S; Motomura H; Ohsawa M; Hirakawa K; Ohira M
Anticancer Res; 2018 Jan; 38(1):401-410. PubMed ID: 29277801
[TBL] [Abstract][Full Text] [Related]
18. Microtubule-Targeting Agents Eribulin and Paclitaxel Differentially Affect Neuronal Cell Bodies in Chemotherapy-Induced Peripheral Neuropathy.
Benbow SJ; Wozniak KM; Kulesh B; Savage A; Slusher BS; Littlefield BA; Jordan MA; Wilson L; Feinstein SC
Neurotox Res; 2017 Jul; 32(1):151-162. PubMed ID: 28391556
[TBL] [Abstract][Full Text] [Related]
19. Correction: Targeting a ribonucleoprotein complex containing the caprin-1 protein and the c-Myc mRNA suppresses tumor growth in mice: an identification of a novel oncotarget.
Qiu YQ; Yang CW; Lee YZ; Yang RB; Lee CH; Hsu HY; Chang CC; Lee SJ
Oncotarget; 2019 Aug; 10(47):4919. PubMed ID: 31448057
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of p130Cas by angiotensin II is dependent on c-Src, intracellular Ca2+, and protein kinase C.
Sayeski PP; Ali MS; Harp JB; Marrero MB; Bernstein KE
Circ Res; 1998 Jun; 82(12):1279-88. PubMed ID: 9648724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
